Routine staging with endoscopic ultrasound in patients with obstructing esophageal cancer and dysphagia rarely impacts treatment decisions

被引:13
作者
Mansfield, Sara A. [1 ]
El-Dika, Samer [2 ]
Krishna, Somashekar G. [2 ]
Perry, Kyle A. [1 ]
Walker, Jon P. [2 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Gen & Gastrointestinal Surg, 410 West 10th Ave, Columbus, OH 43210 USA
[2] Ohio State Univ, Wexner Med Ctr, Div Gastroenterol Hepatol & Nutr, Sect Adv Endoscopy,Dept Internal Med, 410 West 10th Ave, Columbus, OH 43210 USA
来源
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES | 2017年 / 31卷 / 08期
基金
美国国家卫生研究院;
关键词
Endoscopic ultrasound; Esophageal cancer; Dysphagia; Staging; NEOADJUVANT THERAPY; ULTRASONOGRAPHY; ADENOCARCINOMA; CARCINOMA; PET/CT; TUMORS; NEED;
D O I
10.1007/s00464-016-5351-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Endoscopic ultrasound (EUS) has been routinely utilized for the locoregional staging of esophageal cancer. One important aspect of clinical staging has been to stratify patients to treatment with neoadjuvant chemoradiation or primary surgical therapy. We hypothesized that EUS may have a limited impact on clinical decision making in patients with dysphagia and obstructing esophageal masses. Methods This retrospective cohort study included all patients with esophageal adenocarcinoma undergoing esophageal EUS between July 2008 and September 2013. Dysplastic Barrett's esophagus without invasive adenocarcinoma or incomplete staging was excluded. Patient demographics, endoscopic tumor characteristics, the presence of dysphagia, sonographic staging, and post-EUS therapy were recorded. Pathologic staging for patients who underwent primary surgical therapy was also recorded. Locally advanced disease was defined as at least T3 or N1, as these patients are typically treated with neoadjuvant therapy. Results Two hundred sixteen patients underwent EUS for esophageal adenocarcinoma, with 147 (68.1%) patients having symptoms of dysphagia on initial presentation. Patients with dysphagia were significantly more likely to have locally advanced disease on EUS than patients without dysphagia (p<0.0001). Additionally, 145 (67.1%) patients had a partially or completely obstructing mass on initial endoscopy, of which 136 (93.8%) were locally advanced (p<0.0001 vs. non-obstructing lesions). Conclusions An overwhelming majority of patients presenting with dysphagia and/or the presence of at least partially obstructing esophageal mass at the time of esophageal cancer diagnosis had an EUS that demonstrated at least locally advanced disease. The present study supports the hypothesis that EUS may be of limited benefit for management of esophageal cancer in patients with an obstructing mass and dysphagia.
引用
收藏
页码:3227 / 3233
页数:7
相关论文
共 24 条
  • [21] 2-L
  • [22] An analysis of multiple staging management strategies for carcinoma of the esophagus: Computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy
    Wallace, MB
    Nietert, PJ
    Earle, C
    Krasna, MJ
    Hawes, RH
    Hoffman, BJ
    Reed, CE
    [J]. ANNALS OF THORACIC SURGERY, 2002, 74 (04) : 1026 - 1032
  • [23] Endoscopic Ultrasonography in Esophageal Cancer Leads to Improved Survival Rates: Results From a Population-Based Study
    Wani, Sachin
    Das, Ananya
    Rastogi, Amit
    Drahos, Jennifer
    Ricker, Winifred
    Parsons, Ruth
    Bansal, Ajay
    Yen, Roy
    Hosford, Lindsay
    Jankowski, Meghan
    Sharma, Prateek
    Cook, Michael B.
    [J]. CANCER, 2015, 121 (02) : 194 - 201
  • [24] Endoscopic Ultrasound Staging of Stenotic Esophageal Cancers May Be Unnecessary to Determine the Need for Neoadjuvant Therapy
    Worrell, Stephanie G.
    Oh, Daniel S.
    Greene, Christina L.
    DeMeester, Steven R.
    Hagen, Jeffrey A.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2014, 18 (02) : 318 - 320